Condition: Age-Related Macular Degeneration (AMD) · Diabetic Retinopathy (DR) · Retinal Detachment · Sponsor: Fondazione G.B. Bietti, IRCCS
This prospective interventional translational study aims to identify and validate protein biomarkers associated with major ophthalmological diseases, including age-related macular degeneration, diabetic retinopathy (DR), and retinal detachment (RD). A total of approximately 260 participants (cases and controls) will be enrolled at a single center. Biological samples, including peripheral blood, tears, aqueous humor, vitreous humor, and subretinal fluid, will be collected during routine clinical and surgical procedures. Advanced clinical proteomics approaches will be applied to characterize molecular signatures associated with disease onset, progression, and response to treatment. The study seeks to improve the understanding of disease pathophysiology and support the development of novel diagnostic and prognostic biomarkers in ophthalmology.
This description comes directly from the study's public registry record.
Mariacristina Parravano, MD · +390684009442 · mariacristina.parravano@fondazionebietti.it
Tommaso Rossi, MD · tommaso.rossi@fondazionebietti.it
Always discuss trial participation with your own doctor first.
| IRCCS Fondazione G.B.Bietti | Roma, Italy, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07500324